Skip to main content

Oxford Cannabinoid Technologies "proceeding forward as planned" after review meeting

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP, OTCQB:OCTHF) CEO Clarissa Sowemimo-Coker speaks to Proactive after announcing that a Research Ethics Committee (REC) review meeting for its lead programme OCT461201 has now taken place. Sowemimo-Coker says the company is "proceeding forward as planned" and has "hit the ground running" in 2023.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Recent Quotes

View More
Symbol Price Change (%)
AMZN  232.52
+0.14 (0.06%)
AAPL  273.40
-0.41 (-0.15%)
AMD  214.99
-0.05 (-0.02%)
BAC  56.17
-0.08 (-0.14%)
GOOG  314.96
-0.71 (-0.22%)
META  663.29
-4.26 (-0.64%)
MSFT  487.71
-0.31 (-0.06%)
NVDA  190.53
+1.92 (1.02%)
ORCL  197.99
+0.50 (0.25%)
TSLA  475.19
-10.21 (-2.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.